Compare
CNS vs SPY
Up to five stocks or ETFs side by side. Performance is rebased to 100 at the start of the window.
Relative performance
| CNS | SPY | |
|---|---|---|
| Price | $73.20 | $735.29 |
| 1-day | -0.04% | +0.31% |
| YTD | +16.60% | +7.83% |
| 1 year | +6.95% | +8.52% |
| 3 years | +38.37% | +73.97% |
| Market cap | $3.8B | — |
| P/E | 22.5 | — |
| P/S | 6.28 | — |
| P/B | 6.20 | — |
| Revenue growth | +8.60% | — |
| EPS growth | +1.90% | — |
| Gross margin % | — | — |
| Net margin % | 28.2 | — |
| ROE % | 27.8 | — |
| Debt / equity | 0.00 | — |
| FCF yield % | 1.0 | — |
| Dividend yield % | 3.59 | — |
| Beta | 0.59 | 1.00 |
| RSI (14) | 52.1 | 35.1 |
| Technical rating |